Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic pens are designed with a tiered dosing system where a single 1mg pen delivers exactly four separate injections. Understanding this structure helps patients and providers manage both the medication schedule and the financial aspects of GLP-1 weight loss therapy.

How Doses Are Distributed in a 1mg Ozempic Pen

Each 1mg Ozempic pen contains medication divided into four equal doses of 0.25mg each. This design reflects the standard titration protocol approved for weight management, where patients begin at the lowest dose and gradually increase their injection strength over one month. The pen's mechanism allows healthcare providers to dial the exact dose needed before each weekly injection, making it straightforward for patients to follow their personalized treatment plan.

The four-dose structure is intentional: it matches the weekly injection schedule for the first four weeks of treatment. Week one uses 0.25mg, week two uses 0.25mg, week three uses 0.25mg, and week four uses 0.25mg, completing the full 1mg pen. After this initial month, many patients move to higher-dose pens or continue on the 1mg if their provider determines that dose level is optimal for their weight loss goals.

Understanding Semaglutide Dosing Progression Beyond the First Pen

Once patients complete the initial 1mg pen, treatment typically progresses to 2mg and 4mg pens for the maintenance phase. A 2mg pen also delivers four weekly doses, but each dose is 0.5mg, providing a stronger effect on appetite regulation and glucose metabolism. The 4mg pen follows the same pattern with four 1mg doses per pen, representing the highest standard maintenance dose for weight loss therapy.

This escalation allows the body to adapt gradually to semaglutide's effects while minimizing nausea and gastrointestinal side effects. Most patients experience meaningful weight loss results at the 1mg or 2mg dose level, though some benefit from the full 4mg dose. The key principle is that dose increases happen on a weekly basis only after the patient has tolerated the previous dose for at least one week.

Price Stability Across Dose Levels at PlexusDx

PlexusDx compounded semaglutide injection maintains a flat monthly price of $149 regardless of whether a patient is taking 0.25mg, 2mg, or 4mg per week. This pricing model removes the financial barriers that often discourage patients from increasing their dose when clinically appropriate. Many other semaglutide providers charge more for higher-dose pens, creating an incentive to stay at suboptimal doses—a practice PlexusDx explicitly avoids.

The guarantee 'Your dose may need to go up. Your price won't' means patients can focus entirely on their health outcomes rather than cost concerns when their provider recommends a dose increase. PlexusDx sources all compounded semaglutide from licensed 503A compounding pharmacies and serves all 50 states without insurance requirements, HSA and FSA eligibility, or membership fees.

How Personalized Genetic Testing Optimizes Your Semaglutide Response

PlexusDx Precision Peptide Genetic Test identifies how your body processes GLP-1 receptor signaling, helping predict your optimal dose and expected response timeline. The test analyzes key genetic variants including GLP1R rs6923761 and GIPR rs1800437, which directly influence semaglutide effectiveness. Patients with specific genetic profiles may need lower doses to achieve results or may require higher doses to experience the same benefit as others.

Adding the Precision Peptide Genetic Test ($99 after your first month of treatment) provides a map of 14 metabolic pathways and 150+ personalized insights. This data-driven approach reduces guesswork during the titration phase and helps your provider design a dosing schedule aligned with your unique peptide pathway biology. Rather than following a one-size-fits-all protocol, you receive recommendations calibrated to your genetic predispositions.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many times can I use one Ozempic pen if it contains 1mg?

A single 1mg Ozempic pen provides exactly four weekly injections: four doses of 0.25mg each. After four weeks, the pen is empty and a new pen is required. PlexusDx compounded semaglutide injection pens follow the same structure and dosing schedule.

Can I stay on the 0.25mg dose if I'm getting good results?

Yes, if your provider determines that 0.25mg is delivering your weight loss goals and you're tolerating it well, you can remain on that dose. However, most patients continue titrating through 0.5mg, 1mg, and beyond for sustained results. Your PlexusDx provider will monitor your progress and adjust based on your clinical response.

Why does PlexusDx charge the same price for all semaglutide doses?

PlexusDx operates on a dose-stable pricing model because your health outcome should never be limited by cost. Whether you need 0.25mg or 4mg weekly, compounded semaglutide injection costs $149/month flat. This eliminates financial barriers to reaching your optimal therapeutic dose.

What happens if I experience severe nausea at a higher dose?

If side effects become intolerable, your PlexusDx provider can pause your dose increase, hold at your current level for extra weeks, or reduce to a previous dose. Nausea typically decreases after 2–3 weeks as your body adapts. Staying well-hydrated, eating small frequent meals, and avoiding fatty foods help many patients manage this transition symptom.

How does the Precision Peptide Genetic Test help with dosing?

The test identifies genetic variants in GLP1R, GIPR, FTO, and MC4R pathways that influence how quickly your body responds to semaglutide and what dose level works best. Patients with certain genetic profiles may achieve results at lower doses, reducing side effects and costs. This personalized insight helps your provider design your optimal titration schedule.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves